Exhibit 99.1 Ginkgo Bioworks Reports Second Quarter 2025 Financial Results Ginkgo provides an update on its restructuring, including achievement of its expanded $250 million cost savings targets BOSTON, Mass – August 7, 2025 – Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced its results for the second quarter ended June 30, 2025. The update, including a webcast slide presentation with additional details on the ...